Two faces of ALS | UAntwerp

by Biotech Newsroom


Two patients with amyotrophic lateral sclerosis (ALS) may share the same symptoms, yet their brains may be fighting entirely different battles. Prof. Philip Van Damme, neurologist at UZ Leuven, and Prof. Renzo Mancuso of the VIB-UAntwerp Center for Molecular Neurology uncovered fundamental differences in the brain’s immune response between inherited and non-inherited forms of ALS.

ALS is a deadly disease affecting approx. 1 in 400 adults. Patients are confronted with a gradually increasing loss of the neural cells that control the…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC